Meeting
2019 ASCO Annual Meeting
A novel association between GSTM1 null variant and anthracycline-induced cardiac dysfunction (ACD) in childhood cancer survivors (CCS): A COG ALTE03N1 report.
Authors
Purnima Singh
University of Alabama at Birmingham, Birmingham, AL
Purnima Singh , Xuexia Wang , Lindsey Hageman , Yanjun Chen , Tarek Magdy , Wendy Landier , Jill P. Ginsberg , Joseph Philip Neglia , Charles A. Sklar , Sharon M. Castellino , ZoAnn Eckert Dreyer , Melissa M. Hudson , Leslie L. Robison , Javier G. Blanco , Mary V. Relling , Paul Burridge , Smita Bhatia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Leukemia/Lymphoma
Citation
J Clin Oncol 37, 2019 (suppl; abstr 10030)
DOI
10.1200/JCO.2019.37.15_suppl.10030
Abstract #
10030
Poster Bd #
412
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from Children’s Oncology Group and Childhood Cancer Survivor Study.
First Author: Noha Sharafeldin
Poster
2014 ASCO Annual Meeting
Myocardial strain for detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: Results from the St. Jude lifetime cohort study.
First Author: Gregory T. Armstrong
Poster
2013 ASCO Annual Meeting
Comprehensive profiling of cardiac dysfunction in asymptomatic childhood cancer survivors (CCS) treated with anthracyclines.
First Author: Saro Armenian
Poster
2023 ASCO Annual Meeting
Genetic study of type 2 diabetes risk in diverse populations of survivors of childhood cancer: A report from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor Study (CCSS).
First Author: Cindy Im